R. A. Ramos,Y. Nishio, A. C. Maiyar, K. E. Simon ,C. C. Ridder, Y. Ge and G. L. Firestone, “Glucocorticoid- Sti- mulated CCAAT/Enhancer-Binding Protein Alpha Expression is Required for Steroid-Induced G1 Cell Cycle Arrest of Minimal-Deviation Rat Hepatoma Cells,” Molecular and Cellular Biology, Vol. 16, No. 10, October 1996, pp. 5288-5301.

has been cited by the following article:

• TITLE: Cytotoxic Effect of Dexamethasone Restricted to Noncycling, Early G1 Phase of Melanoma Cells

  AUTHORS: Abdel-Moneim M. Osman, Mansour I. Sulaiman, Zoheir A. Damanhouri

  KEYWORDS: Melanoma Cells, Cell Fractionation, Dexamethasone

  JOURNAL NAME: Journal of Cancer Therapy, Vol.2 No.2, June 29, 2011

  ABSTRACT: This study deals with the inhibitory effects of dexamethsone on the proliferation of a human melanoma cells after separation into different fractions according to their position in the cell cycle using a gravity sedimentation chamber. Fractions with high percentage of G1 cells were more susceptible to the action of dexamethsone than those with a lower percentage of G1 cells. Dexamethsone stimulated the rate of incorporation of radioactive precursors into acid-precipitable materials of melanoma M-5A cells starting 24 hours after treatment for one hour. Moreover, dexamethsone treatment markedly increased the volume of the M-5A cells with increasing the possibility of stimulating the transcriptional/translational activity in the cells. This study may hopefully stimulate the development of new approaches in systemic and/or regional chemotherapy with malignant melanoma using dexamethsone with other alkylating agents to get synergestic interaction.